ClinConnect ClinConnect Logo
Search / Trial NCT06648018

Comparison of Nutritional Information With Iron-succinate Supplementation in Healthy Women

Launched by UNIVERSITY HOSPITAL, LINKOEPING · Oct 11, 2024

Trial Information

Current as of July 24, 2025

Enrolling by invitation

Keywords

Nutrition Exercise Iron Well Being

ClinConnect Summary

Aim The primary aim of the current study is to evaluate the effects of dietary nutritional advice with regards to iron rich food sources or a daily oral supplement of 100 mg ferrous iron succinate in 80 menstruating, healthy women aged 20-40 years.

Methods The study will use a randomized controlled non-blinded design, and 80 healthy women aged 20-40 years whom regularly exercise will be included. Data collection will be made through online, standardized forms using the digital platform REDCap 13.1.28 (Vanderbilt University, Nashville, TN, USA). Study personnel will register laboratory and ...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria: Inclusion criteria will be menstruating women aged 20 to 40 years who are healthy and regularly exercise.
  • -
  • Exclusion Criteria: Significant disease affecting inflammation and/or hemoglobin levels. Inability to cooperate or to fill out questionnaires.
  • -

About University Hospital, Linkoeping

The University Hospital in Linköping is a leading academic medical center renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pivotal institution within the region, it integrates cutting-edge medical practices with academic excellence, facilitating a collaborative environment for healthcare professionals and researchers. The hospital actively participates in a wide range of clinical trials across various medical disciplines, aiming to enhance patient outcomes and contribute to the global body of medical knowledge. With a focus on ethical standards and patient safety, the University Hospital in Linköping is dedicated to pioneering solutions that address pressing health challenges.

Locations

Linköping, , Sweden

Patients applied

0 patients applied

Trial Officials

Fredrik H Nyström, MD PhD Professor

Principal Investigator

Linkoeping University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported